(Q36645170)

15 August 2017

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients (English)

1 reference

15 August 2017

0 references

9

Richard M Ransohoff

1 reference

15 August 2017

Linda A Lieberman

1

1 reference

15 August 2017

Wanyong Zeng

2

1 reference

15 August 2017

Carol Singh

3

1 reference

15 August 2017

Wenting Wang

4

1 reference

15 August 2017

Kevin L Otipoby

5

1 reference

15 August 2017

Christine Loh

6

1 reference

15 August 2017

Tatiana Plavina

7

1 reference

15 August 2017

Leonid Gorelik

8

1 reference

15 August 2017

Ellen Cahir-McFarland

10

1 reference

15 August 2017

language of work or name

English

0 references

publication date

30 December 2015

1 reference

15 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Neurology

1 reference

15 August 2017

86

1 reference

15 August 2017

4

1 reference

15 August 2017

375-381

1 reference

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

IV immunoglobulin confounds JC virus antibody serostatus determination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

In vivo modulation of the inflammatory response by nonsteroidal antiinflammatory drug-related compounds that trigger L-selectin shedding.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Natalizumab in the treatment of multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Five days of head-down-tilt bed rest induces noninflammatory shedding of L-selectin.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776091

Effects of cryopreservation with polyethylene glycol on the expression of CD11b and CD62L on the surface of polymorphonuclear leukocytes

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26718566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0000000000002314

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

26718566

1 reference